Racial and Socioeconomic Disparities in Time to Treatment Initiation in Acute Myeloid Leukemia

Authors

• Michael Amankwaah, Lincoln Memorial UniversityFollow
• Bryan Ortiz, Touro College of Osteopathic Medicine
• Katherine Zhou, Virginia Commonwealth University
• Thuy Ho, Virginia Commonwealth University
• Patrick Willard, Virginia Commonwealth University
• Jinlei Zhao, Virginia Commonwealth University
• Faith Reed, Virginia Commonwealth University
• Keri R. Maher, Virginia Commonwealth University

Document Type

Presentation

Publication Date

Fall 10-5-2026

Abstract

Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy with poor prognosis in adults despite therapeutic advances. Although cytomolecular risk, functional status, and comorbidities are established prognostic factors, social determinants of health (SDOH), including socioeconomic factors, geographic location, literacy, social support, and structural racism, may also influence AML care and outcomes. This study examined whether SDOH burden was associated with time to treatment initiation and early mortality.

Recommended Citation

Amankwaah, Michael; Ortiz, Bryan; Zhou, Katherine; Ho, Thuy; Willard, Patrick; Zhao, Jinlei; Reed, Faith; and Maher, Keri R., "Racial and Socioeconomic Disparities in Time to Treatment Initiation in Acute Myeloid Leukemia" (2026). DO Research Day. 15.
https://digitalcommons.lmunet.edu/doresearch/15